Clinical trials of CD19-targeted CAR-modified T cell therapy; a complex and varied landscape
Author:
Publisher
Informa UK Limited
Subject
Hematology
Link
http://www.tandfonline.com/doi/pdf/10.1080/17474086.2016.1203251
Reference20 articles.
1. Chimeric antigen receptor modified T cell therapy for B cell malignancies
2. Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
3. Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
4. Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor
5. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. When Onco-Immunotherapy Meets Cold Atmospheric Plasma: Implications on CAR-T Therapies;Frontiers in Oncology;2022-02-23
2. Robust CAR-T memory formation and function via hematopoietic stem cell delivery;PLOS Pathogens;2021-04-01
3. CAR T cell therapy as a promising approach in cancer immunotherapy: challenges and opportunities;Cellular Oncology;2021-03-24
4. Proceedings From the First International Workshop at Sidra Medicine: “Engineered Immune Cells in Cancer Immunotherapy (EICCI): From Discovery to Off-the-Shelf Development”, 15th–16th February 2019, Doha, Qatar;Frontiers in Immunology;2021-01-14
5. Current Progress in CAR-T Cell Therapy for Hematological Malignancies;Journal of Cancer;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3